Hanmi Pharm. Co., Ltd. (KRX:128940)
436,500
+22,000 (5.31%)
May 21, 2026, 3:30 PM KST
52.62% (1Y)
| Market Cap | 5.26T +73.1% |
| Revenue (ttm) | 1.55T +3.5% |
| Net Income | 169.55B +39.8% |
| EPS | 13,362.00 +39.7% |
| Shares Out | 12.68M |
| PE Ratio | 31.02 |
| Forward PE | 27.55 |
| Dividend | 2,000.00 (0.46%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 90,898 |
| Average Volume | 118,729 |
| Open | 418,500 |
| Previous Close | 414,500 |
| Day's Range | 416,000 - 450,000 |
| 52-Week Range | 267,500 - 647,000 |
| Beta | 0.43 |
| RSI | 36.79 |
| Earnings Date | Apr 30, 2026 |